E‐E Ke
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
-
- Colorectal Cancer Treatments and Studies
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
-
- Lung Cancer Treatments and Mutations 10
- Lung Cancer Diagnosis and Treatment 2
- Metastasis and carcinoma case studies 1
- Oncology 5
- Lung Cancer Research Studies 2
- Cancer Immunotherapy and Biomarkers 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Yi-Long Lung Cancer Wu (8 shared papers)Qing Hua Zhou (7 shared papers)Xu‐Chao Zhang (6 shared papers)Zhihong Chen (5 shared papers)Jin‐Ji Yang (4 shared papers)Feiyu Niu (3 shared papers)Qiuyi Zhang (3 shared papers)Jian Zhong Su (5 shared papers)
In The Last Decade
E‐E Ke
14 papers receiving 576 citations
Peers
Comparison fields: 5 of 49
- Pulmonary and Respiratory Medicine 396
- Oncology 227
- Cancer Research 87
- Molecular Biology 125
- Otorhinolaryngology 5
Countries citing papers authored by E‐E Ke
This map shows the geographic impact of E‐E Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E‐E Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E‐E Ke more than expected).
Fields of papers citing papers by E‐E Ke
This network shows the impact of papers produced by E‐E Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E‐E Ke. The network helps show where E‐E Ke may publish in the future.
Co-authors
The 25 scholars most cited alongside E‐E Ke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 155 | |
| 2 | 2016 | 119 | |
| 3 | 2017 | 82 | |
| 4 | 2018 | 68 | |
| 5 | 2024 | 50 | |
| 6 | 2023 | 23 | |
| 7 | 2015 | 19 | |
| 8 | 2021 | 15 | |
| 9 | 2021 | 15 | |
| 10 | 2016 | 14 | |
| 11 | 2016 | 9 | |
| 12 | 2024 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2022 | 2 | |
| 15 | 2017 | 0 |
About E‐E Ke
E‐E Ke is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Immunology and Allergy and Orthopedics and Sports Medicine, having authored 15 papers that have together received 584 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (10 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Research Studies (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Cell Adhesion Molecules Research (1 paper) and Metastasis and carcinoma case studies (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (396 citations), Oncology (227 citations), Cancer Research (87 citations), Molecular Biology (125 citations) and Otorhinolaryngology (5 citations). E‐E Ke has collaborated with scholars based in China, Norway and India. Frequent co-authors include Yi-Long Lung Cancer Wu, Qing Hua Zhou, Xu‐Chao Zhang, Zhihong Chen, Jin‐Ji Yang, Feiyu Niu, Qiuyi Zhang, Jian Zhong Su, Wen‐Zhao Zhong and Yichen Zhang. Their work appears in journals such as Journal of Thoracic Oncology, 中国科学通报：英文版, Oncotarget, Bone Research and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.